S&P 500 7,376.86 +0.31%
Nasdaq 24,579.42 +1.09%
S&P/TSX 35,789.09 +0.52%
Apple 342.37 −0.52%
Nvidia 186.64 +2.78%
Microsoft 530.61 −0.99%
Shopify 210.47 +4.59%
Royal Bank 284.16 −0.59%
CAD/USD 0.7078 −0.79%
CLOSED · 05:55 ET
Market ClerkRecap
Sun Nov 8 · markets closed4 signals on Nov 7227 insider buys this week · $429.6MCIRO short report next: Nov 15The week ahead

NEOG

NEOGEN CORP
NASDAQ · HEALTH CARE · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
11.76
+0.08 +0.68%
USD · Nov 6, 06:40 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Financials

SEC XBRL · 64 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q1 2027 · Aug 31$222.8M+6.5%47.4%−$1.8M−$11.9M−132.8%-0.05$12.9M$8.2M$4.7MOct 7
Q4 2026 · May 31derived$225.3M−0.1%47.8%$3.1M−$11.3M—-0.06$30.2M$4M$26.2MJul 30
Q3 2026 · Feb 28$211.2M−4.4%46.9%−$3.3M−$17M—-0.08$22.7M$11.6M$11.1MApr 9
Q2 2026 · Nov 30$224.7M−2.8%47.5%−$5.4M−$15.9M—-0.07$19.5M$11.7M$7.8MJan 8
Q1 2026 · Aug 31$209.2M−3.6%45.4%−$16.1M$36.3M—0.17$10.8M$24M−$13.2MOct 7
Q4 2025 · May 31derived$225.5M−4.8%41.2%−$611.2M−$612.2M—-2.82$16.4M$16.1M$300KJul 30
Q3 2025 · Feb 28$221M−3.4%49.9%$5.4M−$10.9M—-0.05$19.5M$32.9M−$13.4MApr 9
Q2 2025 · Nov 30$231.3M+0.7%49.0%−$457.5M−$456.3M—-2.10$40.3M$17.2M$23.1MJan 8
Q1 2025 · Aug 31$217M—48.4%$2.3M−$12.6M—-0.06−$17.9M$38.4M−$56.3MOct 9
Q4 2024 · May 31derived$236.8M—47.9%$13M−$5.4M—-0.02$26.8M$24.2M$2.5MJul 30
Q3 2024 · Feb 29$228.8M—51.1%$12M−$2M—-0.01−$30.2M$32.1M−$62.3MApr 9
Q2 2024 · Nov 30$229.6M—50.9%$14.5M−$3.5M—-0.02$15.7M$24.4M−$8.7MJan 15

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2026 · to May 31$870.4M46.9%−$21.6M−$7.9M-0.9%-0.04$83.2M$51.3M$31.9M——
FY2025 · to May 31$894.7M47.1%−$1.1B−$1.1B-122.1%-5.03$58.2M$104.6M−$46.4M——
FY2024 · to May 31$924.2M50.2%$58.6M−$9.4M-1.0%-0.04$35.3M$111.4M−$76.1M——
FY2023 · to May 31$822.4M49.4%$37.5M−$22.9M-2.8%-0.12$41M$65.8M−$24.7M——
FY2022 · to May 31$527.2M46.1%$58.6M$48.3M9.2%0.45$68M$24.4M$43.6M——
FY2021 · to May 31$468.5M45.9%$74.2M$60.9M13.0%0.57$81.1M$26.7M$54.4M——

Every number comes from NEOGEN CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch NEOG. Know when insiders buy.
One email the day a filing lands. Free.